Affymetrix Files for FDA Clearance of CytoScan HD | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix has filed its CytoScan cytogenetics platform with the US Food and Drug Administration, a company official said at the Leerink Swann Global Healthcare Conference yesterday.

"We have ... completed the CytoScan filing with the FDA," Affy CFO Tim Barabe said at the conference. "So it's in the works, it's with them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.